title: Monte Carlo characterization of biocompatible beta-emitting 90Y glass seed incorporated with the radionuclide 153Sm as a SPECT marker for brachytherapy applications.
abstract: A glass seed consisting of the β--emitting radionuclide 90Y incorporated with radionuclide 153Sm as SPECT marker is proposed for potential application in brachytherapy in order to reduce the undesirable dose to healthy adjacent organs. The aim of this work is to determine the dosimetric characteristics, as suggested in the AAPM TG-60/TG-149 reports, for this seed using Monte Carlo simulation. Monte Carlo codes MCNP5, EGSnrc, and FLUKA were used to calculate the absorbed dose distribution around the seed. Dosimetric parameters, such as reference absorbed dose rate, radial dose function, and one-dimensional (1D) and two-dimensional (2D) anisotropy functions, were obtained. The computational results from these three codes are in agreement within 5.4% difference on average. The absorbed dose rate at the reference point was estimated to be 5.01 cGy h-1 μCi-1 and self absorption of YAS glass seed amounted to 30.51%. The results showed that, with thermal neutron bombardment of 5 hours in a typical flux, sufficient activity for applications in brachytherapy may be achieved. With a 5 mCi initial activity, the total dose of a YAS glass seed was estimated to be 1.38 Gy at 1.0 cm from the seed center. Comparing with gamma emitting seeds, the 90Y seed could reduce undesirable doses to adjacent organs, because of the rapid dose falloff of beta ray. Because of the high R90 value of 5.5 mm, fewer number of 90Y seeds will be required for an interstitial brachytherapy treatment using permanent implant, in comparison with other beta-emitting seeds. The results would be helpful in the development of the radioactive implants using 90Y glass seeds for the brachytherapy treatment.
authors.affiliation: Islamic Azad University. a.hadadi@srbiau.ac.ir.
authors.forename: Asghar
authors.initials: A
authors.lastname: Hadadi
authors.forename: Mahdi
authors.initials: M
authors.lastname: Sadeghi
authors.forename: Dariush
authors.initials: D
authors.lastname: Sardari
authors.forename: Alireza
authors.initials: A
authors.lastname: Khanchi
authors.forename: Alireza
authors.initials: A
authors.lastname: Shirazi
mesh_terms: D016880:Anisotropy; D001610:Beta Particles; D001672:Biocompatible Materials; D001918:Brachytherapy; D006801:Humans; D009010:Monte Carlo Method; D009369:Neoplasms / Q000532:radiotherapy*; D019047:Phantoms, Imaging; D011874:Radiometry; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D012493:Samarium; D015899:Tomography, Emission-Computed, Single-Photon; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
chemical_list: D001672:Biocompatible Materials; D015021:Yttrium Radioisotopes; D012493:Samarium
references.citation: Med Phys. 2011 Aug;38(8):4824-45
references.pmid: 21928655
references.citation: Nature. 1956 Dec 1;178(4544):1240-1
references.pmid: 13387682
references.citation: Med Phys. 2004 Mar;31(3):633-74
references.pmid: 15070264
references.citation: Cardiovasc Radiat Med. 2001 Apr-Jun;2(2):83-92
references.pmid: 11340012
references.citation: Appl Radiat Isot. 2008 Apr;66(4):441-9
references.pmid: 18171619
references.citation: Clin Radiol. 1998 Aug;53(8):604-7
references.pmid: 9744588
references.citation: J ICRU. 2004 Dec;4(2):5-8
references.pmid: 24170823
references.citation: Med Phys. 1999 Feb;26(2):119-52
references.pmid: 10076966
references.citation: Appl Radiat Isot. 2010 Dec;68(12):2157-62
references.pmid: 20685128
references.citation: Med Phys. 2010 Oct;37(10):5370-5
references.pmid: 21089772
references.citation: Cardiovasc Radiat Med. 2002 Jan-Mar;3(1):31-43
references.pmid: 12479914
references.citation: Artif Organs. 2003 May;27(5):432-6
references.pmid: 12752203
references.citation: Med Phys. 2007 Jun;34(6):2187-205
references.pmid: 17654921
references.citation: J Biomed Mater Res. 1993 Oct;27(10):1301-8
references.pmid: 8245044
references.citation: Med Phys. 2007 Nov;34(11):4126-57
references.pmid: 18072478